Experimental gene therapy successful in certain lymphomas, leukemia

Study results of CD19-directed chimeric antigen receptor therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with advanced hematologic malignancies, experts report. Study results of CD19-directed chimeric antigen receptor therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with advanced hematologic malignancies.

http://ift.tt/1w8vJ1G